Ligand Partner Viking Therapeutics Announces Closing of Initial Public Offering
Go back to Ligand Partner Viking Therapeutics Announces Closing of Initial Public Offering| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 286.92 +2.65 (0.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $284.27 | 52 Week High | $139.79 | |||
| Open | $285.73 | 52 Week Low | $82.07 | |||
| Day High | $290.33 | P/E | 667.26 | |||
| Day Low | $281.69 | EPS | $0.43 | |||
| Volume | 189,616 | |||||
| ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) | Delayed: 33.50 -0.17 (0.5%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $33.67 | 52 Week High | $5.17 | |||
| Open | $33.67 | 52 Week Low | $0.94 | |||
| Day High | $34.75 | P/E | N/A | |||
| Day Low | $32.77 | EPS | $0.00 | |||
| Volume | 1,573,315 | |||||
